Skip to content

Mapping dopaminergic function using phMRI in healthy volunteers and amphetamine users

Mapping dopaminergic function using phMRI in healthy volunteers and amphetamine users - Dopamine phMRI in amphetamine users

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37495
Enrollment
40
Registered
2012-07-26
Start date
2013-01-16
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kinder en jeugd psychatrie addiction Substance dependence

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healty male volunteers, aged between 18 and 30 years. Use of amphetamine on at least 40 occasions in the past year in group of amphetamine users.

Exclusion criteria

Exclusion criteria: Contraindications for MRI (e.g. osteosynthetic material, pacemaker, artificial cardiac valves); claustrophobia. Symptomatic cardiovascular disease, moderate-to-severe hypertension, hyperthyroidism, glaucoma, hypersensitivity or idiosyncrasy to sympathomimetic amines, agitation, and history of drug abuse, or use of psychotropic drugs that affect DA function, such as methylphenidate and cocaine (anamnestic). Finally, cardial conduction disorder (abnormal ECG) en renal disease.

Design outcomes

Primary

MeasureTime frame
BOLD: % change in BOLD signal intensity from baseline (ROI) ASL: % change in CBF from baseline (ROI CBF/100 mg tissue) SPECT: difference in binding ratio between baseline and after d-AMPH administration (striatal ROI binding/binding in occipital cortex)

Secondary

MeasureTime frame
Visual analogue rating scale (VAS) Outcome measures of neuropsychological tests: Stroop Word Colour Test (STROOP), Rey Auditory Verbal Learning Test (RAVLT), Trail Making Test (TMT), Iowa Gambling Task (IGT), Digit Span test, Tower of London Test, Emotional Go-NoGo Task, Attention Network Task

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)